SF2/ASF protein binds to the cap region of human topoisomerase I through two RRM domains
- 3 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 331 (2), 398-403
- https://doi.org/10.1016/j.bbrc.2005.03.180
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The camptothecinsThe Lancet, 2003
- The RNA Splicing Factor ASF/SF2 Inhibits Human Topoisomerase I Mediated DNA RelaxationJournal of Molecular Biology, 2002
- Reconstitution of Enzymatic Activity by the Association of the Cap and Catalytic Domains of Human Topoisomerase IPublished by Elsevier ,2002
- SF2/ASF protein inhibits camptothecin‐induced DNA cleavage by human topoisomerase IEuropean Journal of Biochemistry, 2002
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylationThe EMBO Journal, 1999
- Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.Nucleic Acids Research, 1998
- Specific phosphorylation of SR proteins by mammalian DNA topoisomerase INature, 1996
- cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.Proceedings of the National Academy of Sciences, 1988